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 Introductions: Studies have shown inadequate use of prophylaxis for 
venous thromboembolism (VTE) in hospital admitted medical patients. 
This study aims to evaluate the use of VTE prophylaxis in admitted medical 
patients in a tertiary care teaching hospital.  
 
Methods: This was a cross sectional observational study for three weeks 
from 19 March to 8 April 2017 in patients admitted in the medical ward of 
Patan Hospital, Patan Academy of Health Sciences, Lalitpur, Nepal. Patient 
charts were reviewed for appropriate VTE prophylaxis as per modified 
Padua risk Assessment model. Risks of VTE, presence of bleeding risks, 
demographics (age, BMI), hospital stay were descriptively analysed. 
 
Results: Out of 122 patients, 81 (66.4%) were at risk of VTE. Among 81 at 
risk, 69 were eligible for VTE pharmacoprophylaxis with no risk of bleeding 
only 29 (42%) received pharmacoprophylaxis and 12 eligible for 
prophylaxis but with the risk of bleeding did not receive any prophylaxis. 
Reduced mobility was the most common indication of 
thromboprophylaxis in 79 (64%), followed by acute infection 50 (41%). 
 
Conclusions: There was suboptimal use of thromboprophylaxis in hospital 
admitted medical patients at risk of venous thromboembolism, VTE.  
 
Keywords: admitted medical patients, bleeding risk, thrmboprophylaxis, 
venous thromboembolism VTE   
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Venous thromboembolism (VTE) is a common 
but preventable serious complication in 
hospitalized patients.1 Studies have reported 
hospital acquired VTE prevalence between 
0.8%-11% depending on the patient 
population evaluated.2-3   
 
Prophylaxis is carried out in patients at risk of 
VTE using either drugs (e.g. heparin) or 
mechanical methods (e.g. intermittent 
pneumatic compression boots).4 Studies have 
shown that 21-71% of hospital admitted 
patients are considered to be at risk of VTE 
depending upon the different types of scores 
used5-8 and only about half of them received 
adequate prophylaxis.9,10 There exists 
numerous barriers to prophylaxis use as well as 
lack of universally accepted tools.11, 12 
 
The primary objective of this study was to 
evaluate the adequacy of appropriate VTE 






This was a cross sectional observational study 
among the patients admitted in medical ward 
of Patan Hospital, Patan Academy of Health 
Sciences (PAHS), Lalitpur, Nepal. Data was 
collected from patient charts for three weeks 
from 19th March to 8th April 2017. The medical 
ward included general medical ward, geriatric 
ward and step down. The study was conducted 
as a quality improvement project, an in-built 
teaching learning program of PAHS. The study 
was approved from internship elective 
committee. Patients who were hospitalized for 
more than 3 days in a medical ward and had 
negative history of receiving oral or 
intravenous anticoagulation therapy with 
indications other than thromboprophylaxis 
were included in the study. Patients younger 
than 16 years and/or patients who had 
received recent fibrinolytic therapy were 
excluded. Verbal consent was taken from each 
patient. During the study period, it was assured 
that the doctors of medical wards were not 
aware about the study to prevent Hawthorne 
bias.  
 
Data were collected from patient files, 
medication sheet and patient interview. The 
review of the chart and medication sheet was 
carried out on every 4th day in wards, total 6 
times, based on average stay of patients in 
medical wards in last 3 months.  The average 
stay was calculated from the data (duration of 
stay of discharged patients) provided by the of 
Patan hospital. 
 
The patient interview questionnaire consisted 
of three sections: First section demographic 
characteristics of patient, diagnosis or 
indication of hospital admission, total hospital 
stay at time of encounter, inclusion and 
exclusion criteria. Second section consisted of 
Modified Padua risk Assessment model which 
assessed the risk of VTE in hospitalized medical 
patients.3 This model assesses presence of 
specific risk factors and assigns a score for each 
and total score is calculated at the end.  
 
Factors such as critically ill and inflammatory 
bowel disease (IBD) was assigned 4-points 
each; active cancer, previous VTE, reduced 
mobility, thrombotic condition was assigned 3-
points; recent trauma or surgery was assigned 
2-points and remaining risk factors: age ≥70 
year, heart or respiratory failure, acute 
myocardial infarction or ischemic stroke, acute 
infection or rheumatological disorder, Body 
Mass Index (BMI) more than or equal to 30 and 
ongoing hormonal treatment was assigned 1-
point each. 
 
Score of <4 was considered low VTE risk not 
requiring prophylaxis, score of ≥4 requires 
prophylaxis, pharmacoprophyalxis when no 
bleeding risk present, and mechanical 
prophylaxis when bleeding risks present. Third 
section assesses factors strongly associated 
with bleeding risk such as presence of active 
gastroduodenal ulcer, bleeding in the                     
3 months prior to admission, platelet count     
<50 x 109/L, hepatic failure (INR >1.5 without 
anticoagulants) and uncontrolled systemic 
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risk factor was considered contraindication for 
pharmacological prophylaxis.  
 
Descriptive analysis of data was done using 





Among 148 patients, 22 were excluded as they 
had received recent fibrinolytic therapy. Data 
on 122 patients analysed revealed mean age 
58.95±18.08) years, male 65 (53.3%%), and 
hospital stay 6.2±3.5 days, Table 1.  
 
 
Reduced mobility was the most common risk 
factor for indication of thromboprophylaxis in 
79 (64%) while risk factors such as IBD, recent 
trauma/surgery, hormonal therapy, known 
venous thromboembolism were not present, 
Table 2.  
According to Padua risk assessment score, 81 
(66.4%) patients had high risk of VTE and 
eligible for thromboprophylaxis. Of 81 eligible 
patients 29 (42%) received 
pharmacoprophylaxis and none received 
mechanical prophylaxis, Figure 1.  
 
 
Twelve patients who were at the risk of 
thrombosis, had one or more risks of bleeding, 
hepatic failure 8 (8.6%), bleeding within 3 
months of admission 4 (4.9%), uncontrolled 
systemic hypertension 3 (3.7%), platelet count 
less than 50000/microliter 1 (1.2%) and active 
gastroduodenal ulcer 1 (1.2%). 
 
 
Two patients received pharmacoprophylaxis 
were not eligible for it. Injection Heparin was 
used as pharmacoprophylaxis in 29 (93.5%), 
and 2 (6.5%) received low molecular weight 





Figure 1. Flow chart showing patients at risk of venous thromboembolism (VTE) prophylaxis according to 
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Table 1. Characteristics of patients (122) in medical ward assessed for VTE prophylaxis  
 
 
Characteristic Number Percent (%)  
Male 65 53.2 
Female 57 46.7 
Ward  
General Medicine 33 27 
Stepdown 58 48 
Geriatric 31 25 
Mean Age 58.95±18.08 years  
Mean duration of hospital stay 6.2±3.5  
 
Table 2. Risk factors of patients (122) in medical ward assessed for VTE prophylaxis according to Padua risk 
model 
 
Risk Factors  Number (%)   
Reduced mobility 79 (64) 
Acute Infection 50 (41) 
Age more than >70 years 45 (37) 
Heart/Respiratory failure 28 (23) 
Critically ill patients 18 (15) 
Acute MI/Stroke 4 (3) 
Cancer 7 (6) 




In this study, 81 (66.4%) patients had high risk 
of VTE as per Padua Prediction score. The 
proportion of patients at high risk varies in 
different study according to the risk 
assessment models. The Padua Prediction 
score in medical patients followed for up to 90 
days reports the low risk patients with score of 
<4 had 0.3% probability of developing 
symptomatic VTE and high risk patients with 
score of ≥4 had 2.2% (receiving adequate in-
hospital thromboprophylaxis) and 11% (not 
receiving adequate in-hospital 
thromboprophylaxis) probability.3 A Chinese 
study showed that 23.4% of the medical 
patients were classified as high risk by Padua 
risk assessment score, however the same 
study classified 70.9% of patients as high risk 
according to Caprine risk assessment model.7 
An Indian subset of ENDORSE study showed 
44.7% of medical patients were at risk of VTE 
according to American college of chest 
physician guidelines (ACCP) guidelines.8 A 
Canadian study which used Padua and the 
IMPROVE predictive risk assessment models, 
only 21.5% and 7.0% of the patients, 
respectively, were eligible for 
thromboprophylaxis at the time of 
admission.13 
 
The ACCP guidelines recommends 
anticoagulant thromboprophylaxis for acutely 
ill hospitalized medical patients at increased 
risk of thrombosis. For acutely ill hospitalized 
medical patients at increased risk of 
thrombosis who are bleeding or are at high risk 
for major bleeding, it suggests mechanical 
thromboprophylaxis with graduated 
compression stockings or intermittent 
pneumatic compression.1 
 
The most common risk factor in present study 
was reduced mobility 79 (64%), acute infection 
or rheumatological disorder 50 (41%), 
advanced age 45 (37%), and 
cardiac/respiratory failure 28 (23%). This is 
similar to the Italian study which showed most 
common risk factor was reduced mobility, 
advanced age, cardiac/respiratory failure and 
acute infection/rheumatological disorder.14  
Reduced mobility was the most common risk 
factor which might be due to our deeply rooted 
cultural practices that anyone who is admitted 
in hospital should take rest and lie in the bed 
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After the assessment of thrombotic risks, the 
patients should be assessed for bleeding risk 
before prescribing thromboprophylaxis. 
Among the high-risk patients, 14.8% of 
patients had one or more bleeding risk. Most 
common bleeding risk was hepatic failure 
(PT/INR >1.5) 8.6%, followed by bleeding in last 
3 months 4.9%, others being uncontrolled 
systemic hypertension (3.2%) and low platelets 
counts and active gastroduodenal ulcer each 
1.2%. These factors should be considered 
before prescribing thromboprophylaxis as 
IMPROVE trial showed Active gastroduodenal 
ulcer, prior bleeding and low platelet count 
were the strongest independent risk factors at 
admission for bleeding along with hepatic 
failure among others.15 
 
Our findings show less than half 29 (42%) of 69 
high risk of VTE patients, who had no risks of 
bleeding and were eligible for 
pharmacoprophylaxis, received injection 
heparin or enoxaparin. And, 12 (14.6%) 
patients at high risk of VTE but with risks of 
bleeding who were eligible for mechanical 
prophylaxis, none of them received 
prophylaxis. Inadequate availability and/or 
affordability of different methods of 
mechanical prophylaxis might be the reason 
for not using mechanical prophylaxis.  
 
Studies have shown that the use of 
thromboprophylaxis is suboptimal in acutely ill 
hospitalized patients. The use of 
thromboprophylaxis in our study is similar to 
ENDORSE global study, which showed less than 
40% of at-risk hospitalized medical patients 
receive ACCP-recommended prophylaxis.10  An 
American study showed that 51.81% received 
anticoagulant therapy, 2.48% received 
mechanical compression treatment only 
(stocking or pneumatic compression), and 
4.41% received both during hospitalization.16 
Another multinational study (IMPROVE study) 
showed 50% of patients received in-hospital 
pharmacologic and/or mechanical VTE 
prophylaxis.9 
 
In hospital setting when physicians were not 
informed about the thrombotic risk of their 
patients less than 40% of the patients received 
thromboprophylaxis.3 After the physician were 
made aware of the thrombotic risk as assessed 
with Padua prediction score, the use of 
appropriate thromboprophylaxis increased to 
88.5%.16 
 
This study had certain limitations. This was a 
chart review of admitted patients and 
assessment of bleeding risk requiring 
investigations reports of liver function test, 
prothrombin time, platelets etc. were not 
available in some patients’ file. The exact BMI 
could not be calculated for patients who were 
unable to stand on weight machine because 
only latest known weight was taken as 
reference. Also, we could not analyse the 
availability and/or affordability of mechanical 
prophylaxis.  
 
This study serves as a baseline and provides 
opportunities to improve the quality of care in 
developing appropriate interventions for 
prevention of venous thromboembolism and 
use of thromboprophylaxis. Measures should 
be taken to promote mobility among admitted 
patients as reduced mobility was the 






The study demonstrates the suboptimal use of 
pharmacoprophylaxis in admitted medical 
patients at high risk of venous 
thromboembolism as per Padua Prediction 
score. Less than 50% of eligible patients 
received chemoprophylaxis and none received 
mechanical prophylaxis. Reduced mobility was 
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